BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22982095)

  • 1. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.
    Mancebo A; González-Diéguez ML; Cadahía V; Varela M; Pérez R; Navascués CA; Sotorríos NG; Martínez M; Rodrigo L; Rodríguez M
    Clin Gastroenterol Hepatol; 2013 Jan; 11(1):95-101. PubMed ID: 22982095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Velázquez RF; Rodríguez M; Navascués CA; Linares A; Pérez R; Sotorríos NG; Martínez I; Rodrigo L
    Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study.
    Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
    Ann Intern Med; 2012 Jun; 156(12):841-7, W295. PubMed ID: 22711076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
    Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P
    J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S; Mason A; Eason J; Loss G; Perrillo RP
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
    Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
    Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
    Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
    Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.
    Kwon OS; Jung YK; Bae KS; Kim JH; Kim SG; Kim YS; Lee JI; Lee JW; Kim YS
    Alcohol; 2012 Sep; 46(6):537-41. PubMed ID: 22572059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
    Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
    J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.